PhD, State University of New York at Buffalo (2004)
BS, University of Jordan
Employment:
UB-IRB Committee member, University at Buffalo (2018-present)
Research Director, Medicine, Division of Endocrinology, Diabetes and Metabolism (2005-present)
Research Associate Professor, Endocrinology, State University of New York at Buffalo Jacobs School of Medicine & Biomedical Sciences (2014-present)
Awards and Honors:
Internal Medicine Training Program Teaching appreciation award (2013)
The Pharmacia Corporation International Award for Excellence in Published Clinical Research (2001)
Grants and Sponsored Research:
January 2019–December 2023 Triple therapy for T1DM with insulin, semaglutide and dapagliflozin JDRF Role: Co-Principal Investigator $1,641,000
December 2021–December 2022 Preserving Lean Body Mass During Weight Loss In Elderly Obese Patients With GLP-1 Receptor Agonist Treatment CTSI Role: Principal Investigator $50,000
January 2018–December 2022 An Investigation into the effects of Dapagliflozin on Ketogensis in Type 1 Diabetes AstraZeneca Pharmaceuticals LP Role: Co-Investigator $735,000
July 2021–July 2022 LIGHT-UP Study service contract Gelesis Inc Role: Contributor $371,000
August 2012–July 2017 Liraglutide as an Additional treatment in Type 1 diabetes NIH/NIDDK Role: Co-Investigator
December 2012–November 2016 Effects of liraglutide treatment in overweight or obese patients with type 1 diabetes JDRF Role: Co-Investigator
Makdissi A, Ghanim H, Vora M, Green K, Abuaysheh S, Chaudhuri A, Dhindsa S, Dandona P. (2012) Sitagliptin exerts an antinflammatory action. J Clin Endocrinol Metab (Sep), 97(9): 3333-3341.